Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4624-4632

  Tang, Jun ^a,c   Zhou, Ru ^a   Luger, Dror ^a   Zhu, Wei ^a   Silver, Phyllis B ^a   Grajewski, Rafael S ^a,d   Su, Shao Bo ^a,e   Chan, Chi Chao ^a   Adorini, Luciano ^b,f   Caspi, Rachel R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b BioXell SpA   (Italy)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e SHANTOU UNIVERSITY   (China)

^f INTERCEPT PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HEMATOPOIETIC STEM CELL; INNATE IMMUNITY; LYMPH NODE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH17 CELL; UVEITIS; ANIMAL; CELL CULTURE; CELL LINEAGE; CYTOLOGY; DRUG EFFECT; GENETICS; HELPER CELL; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; ORAL DRUG ADMINISTRATION; RETINA;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNITY; CALCITRIOL; CELL LINEAGE; CELLS, CULTURED; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; RETINA; T-LYMPHOCYTES, HELPER-INDUCER; UVEITIS;

EID: 65249120937     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801543     Document Type: Article

References (43)

1. Deluca, H. F., and M. T. Cantorna. 2001. Vitamin D: its role and uses in immunology. FASEB J. 15: 2579-2585.
2. Adorini, L., and G. Penna. 2008. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4: 404-412.
3. Lemon, B. D., and L. P. Freedman. 1996. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol. Cell. Biol. 16: 1006-1016.
4. 3 receptor: a network of coactivator interactions. Gene 246: 9-21.
5. 3 receptor in the immune system. Arch. Biochem. Biophys. 374: 334-338.
6. Glimcher, L. H. 2001. Lineage commitment in lymphocytes: controlling the immune response. J. Clin. Invest. 108: s25-s30.
7. Ivanov, I. I., L. Zhou, and D. R. Littman. 2007. Transcriptional regulation of Th17 cell differentiation. Semin. Immunol. 19: 409-417. (Pubitemid 351274050)
8. Penna, G., S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, F. Sanvito, C. Doglioni, and L. Adorini. 2006. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. J. Immunol. 177: 8504-8511. (Pubitemid 44895295)
9. 3. Diabetes 51: 2119-2125.
10. Ma, Y., B. Khalifa, Y. K. Yee, J. Lu, A. Memezawa, R. S. Savkur, Y. Yamamoto, S. R. Chintalacharuvu, K. Yamaoka, K. R. Stayrook, et al. 2006. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J. Clin. Invest. 116: 892-904.
11. Mahon, B. D., A. Wittke, V. Weaver, and M. T. Cantorna. 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 89: 922-932.
12. + T cells. J. Immunol. 168: 1181-1189.
13. + T cells to enhance the development of Th2 cells. J. Immunol. 167: 4974-4980.
14. Wittke, A., V. Weaver, B. D. Mahon, A. August, and M. T. Cantorna. 2004. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 173: 3432-3436. (Pubitemid 39142054)
15. Cantorna, M. T., C. E. Hayes, and H. F. DeLuca. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 7861-7864.
16. Daniel, C., N. A. Sartory, N. Zahn, H. H. Radeke, and J. M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324: 23-33. (Pubitemid 350294165)
17. Mathieu, C., and M. Jafari. 2006. Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation. Clin. Nephrol. 66: 275-283. (Pubitemid 44541215)
18. Van de Kerkhof, P. C., N. Wasel, K. Kragballe, F. Cambazard, and S. Murray. 2005. A two-compound product containing calcipotriol and β methasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. Dermatology 210: 294-299.
19. Agarwal, R. K., and R. R. Caspi. 2004. Rodent models of experimental autoimmune uveitis. Methods Mol. Med. 102: 395-419.
20. Caspi, R. R., F. G. Roberge, C. C. Chan, B. Wiggert, G. J. Chader, L. A. Rozenszajn, Z. Lando, and R. B. Nussenblatt. 1988. A new model of autoimmune disease: experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140: 1490-1495.
21. Caspi, R. R., C. C. Chan, B. Wiggert, and G. J. Chader. 1990. The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr. Eye Res. 9(Suppl.): 169-174. (Pubitemid 20295619)
22. Caspi, R. R., C. C. Chan, B. G. Grubbs, P. B. Silver, B. Wiggert, C. F. Parsa, S. Bahmanyar, A. Billiau, and H. Heremans. 1994. Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice. J. Immunol. 152: 890-899. (Pubitemid 2048650)
23. Luger, D., P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C.-C. Chan, and R. R. Caspi. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205: 799-810. (Pubitemid 351549879)
24. Tang, J., W. Zhu, P. B. Silver, S. B. Su, C. C. Chan, and R. R. Caspi. 2007. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J. Immunol. 178: 5578-5587. (Pubitemid 46674353)
25. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151. (Pubitemid 41541792)
26. + T helper cells. Cell 126: 1121-1133.
27. Moody, M. D., S. W. Van Arsdell, K. P. Murphy, S. F. Orencole, and C. Burns. 2001. Array-based ELISAs for high-throughput analysis of human cytokines. BioTechniques 31: 186-190, 192-194.
28. Griffin, M. D., W. H. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, and R. Kumar. 2000. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270: 701-708. (Pubitemid 30444768)
29. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691. (Pubitemid 44036274)
30. McGeachy, M. J., and D. J. Cua. 2007. The link between IL-23 and Th17 cell-mediated immune pathologies. Semin. Immunol. 19: 372-376.
31. Yang, X. O., A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282: 9358-9363.
32. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381. (Pubitemid 46413906)
33. Amadi-Obi, A., C. R. Yu, X. Liu, R. M. Mahdi, G. L. Clarke, R. B. Nussenblatt, I. Gery, Y. S. Lee, and C. E. Egwuagu. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718. (Pubitemid 46889754)
34. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J. Allergy Clin. Immunol. 119: 1218-1224.
35. Penna, G., and L. Adorini. 2000. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411. (Pubitemid 30115468)
36. Eberl, G., and D. R. Littman. 2003. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195: 81-90. (Pubitemid 37153455)
37. He, Y. W., M. L. Deftos, E. W. Ojala, and M. J. Bevan. 1998. RORγt, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9: 797-806.
38. Chen, Z., A. Laurence, and J. J. O'Shea. 2007. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19: 400-408.
39. Takeuchi, A., G. S. Reddy, T. Kobayashi, T. Okano, J. Park, and S. Sharma. 1998. Nuclear factor of activated T cells (NFAT) as a molecular target for 1α,25-dihydroxyvitamin D3-mediated effects. J. Immunol. 160: 209-218. (Pubitemid 28116731)
40. Griffin, M. D., X. Dong, and R. Kumar. 2007. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. Arch. Biochem. Biophys. 460: 218-226.
41. Adorini, L., G. Penna, N. Giarratana, and M. Uskokovic. 2003. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 88: 227-233. (Pubitemid 36119891)
42. Penna, G., S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, and L. Adorini. 2007. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178: 145-153. (Pubitemid 46033595)
43. Amuchastegui, S., K. C. Daniel, and L. Adorini. 2005. Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist. Transplantation 80: 81-87. (Pubitemid 40980899)